Close Menu

NEW YORK – The US Centers for Disease Control and Prevention has publicly posted its assay for novel coronavirus 2019-nCoV and is now developing the test into kits, the agency announced Monday. It plans to distribute the test kits to state health departments and public health labs in the next few weeks.

In a call with the media, Nancy Messonnier, the director of the National Center for Immunization and Respiratory Diseases, said 110 people in 26 states are currently being investigated for 2019-nCoV infection.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.